The global Retinal Drugs and Biologics market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
This report aims to provide a comprehensive presentation of the global market for Retinal Drugs and Biologics, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Retinal Drugs and Biologics. This report contains market size and forecasts of Retinal Drugs and Biologics in global, including the following market information:
- Global Retinal Drugs and Biologics Market Revenue, 2018-2023, 2024-2030, ($ millions)
- Global Retinal Drugs and Biologics Market Sales, 2018-2023, 2024-2030, (K MT)
- Global top five Retinal Drugs and Biologics companies in 2022 (%)
The U.S. Market is Estimated at $ Million in 2022, While China is Forecast to Reach $ Million.
Age Related Macular Degeneration Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of Retinal Drugs and Biologics include ALLERGAN, AbbVie, Alimera Sciences, Janssen Biotech, Swedish Orphan Biovitrum, Roche, Bristol-Myers Squibb, Genzyme and Genentech, etc. in 2022, the global top five players have a share approximately % in terms of revenue.
We surveyed the Retinal Drugs and Biologics manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Retinal Drugs and Biologics Market, by Type, 2018-2023, 2024-2030 ($ Millions) & (K MT)
Global Retinal Drugs and Biologics Market Segment Percentages, by Type, 2022 (%)
- Age Related Macular Degeneration
- Diabetic Retinopathy
- Ocular Inflammatory Disease (Uveitis)
- Macular Hole
Global Retinal Drugs and Biologics Market, by Application, 2018-2023, 2024-2030 ($ Millions) & (K MT)
Global Retinal Drugs and Biologics Market Segment Percentages, by Application, 2022 (%)
Global Retinal Drugs and Biologics Market, By Region and Country, 2018-2023, 2024-2030 ($ Millions) & (K MT)
Global Retinal Drugs and Biologics Market Segment Percentages, By Region and Country, 2022 (%)
- North America
- US
- Canada
- Mexico
- Europe
- Germany
- France
- U.K.
- Italy
- Russia
- Nordic Countries
- Benelux
- Rest of Europe
- Asia
- China
- Japan
- South Korea
- Southeast Asia
- India
- Rest of Asia
- South America
- Brazil
- Argentina
- Rest of South America
- Middle East & Africa
- Turkey
- Israel
- Saudi Arabia
- UAE
- Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
- Key companies Retinal Drugs and Biologics revenues in global market, 2018-2023 (Estimated), ($ millions)
- Key companies Retinal Drugs and Biologics revenues share in global market, 2022 (%)
- Key companies Retinal Drugs and Biologics sales in global market, 2018-2023 (Estimated), (K MT)
- Key companies Retinal Drugs and Biologics sales share in global market, 2022 (%)
Key players include:
- ALLERGAN
- AbbVie
- Alimera Sciences
- Janssen Biotech
- Swedish Orphan Biovitrum
- Roche
- Bristol-Myers Squibb
- Genzyme
- Genentech
- OCULAR THERAPEUTIX
- Bausch & Lomb
- UCBCares
Outline of Major Chapters:
Chapter 1: Introduces the definition of Retinal Drugs and Biologics, market overview.
Chapter 2: Global Retinal Drugs and Biologics market size in revenue and volume.
Chapter 3: Detailed analysis of Retinal Drugs and Biologics manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Retinal Drugs and Biologics in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Global Retinal Drugs and Biologics capacity by region & country.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 11: The main points and conclusions of the report.
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 Retinal Drugs and Biologics Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Retinal Drugs and Biologics Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Retinal Drugs and Biologics Overall Market Size
2.1 Global Retinal Drugs and Biologics Market Size: 2022 VS 2030
2.2 Global Retinal Drugs and Biologics Revenue, Prospects & Forecasts: 2018-2030
2.3 Global Retinal Drugs and Biologics Sales: 2018-2030
3 Company Landscape
3.1 Top Retinal Drugs and Biologics Players in Global Market
3.2 Top Global Retinal Drugs and Biologics Companies Ranked by Revenue
3.3 Global Retinal Drugs and Biologics Revenue by Companies
3.4 Global Retinal Drugs and Biologics Sales by Companies
3.5 Global Retinal Drugs and Biologics Price by Manufacturer (2018-2023)
3.6 Top 3 and Top 5 Retinal Drugs and Biologics Companies in Global Market, by Revenue in 2022
3.7 Global Manufacturers Retinal Drugs and Biologics Product Type
3.8 Tier 1, Tier 2 and Tier 3 Retinal Drugs and Biologics Players in Global Market
3.8.1 List of Global Tier 1 Retinal Drugs and Biologics Companies
3.8.2 List of Global Tier 2 and Tier 3 Retinal Drugs and Biologics Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type - Global Retinal Drugs and Biologics Market Size Markets, 2022 & 2030
4.1.2 Age Related Macular Degeneration
4.1.3 Diabetic Retinopathy
4.1.4 Ocular Inflammatory Disease (Uveitis)
4.1.5 Macular Hole
4.2 By Type - Global Retinal Drugs and Biologics Revenue & Forecasts
4.2.1 By Type - Global Retinal Drugs and Biologics Revenue, 2018-2023
4.2.2 By Type - Global Retinal Drugs and Biologics Revenue, 2024-2030
4.2.3 By Type - Global Retinal Drugs and Biologics Revenue Market Share, 2018-2030
4.3 By Type - Global Retinal Drugs and Biologics Sales & Forecasts
4.3.1 By Type - Global Retinal Drugs and Biologics Sales, 2018-2023
4.3.2 By Type - Global Retinal Drugs and Biologics Sales, 2024-2030
4.3.3 By Type - Global Retinal Drugs and Biologics Sales Market Share, 2018-2030
4.4 By Type - Global Retinal Drugs and Biologics Price (Manufacturers Selling Prices), 2018-2030
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Retinal Drugs and Biologics Market Size, 2022 & 2030
5.1.2 Hospitals
5.1.3 Clinics
5.1.4 Others
5.2 By Application - Global Retinal Drugs and Biologics Revenue & Forecasts
5.2.1 By Application - Global Retinal Drugs and Biologics Revenue, 2018-2023
5.2.2 By Application - Global Retinal Drugs and Biologics Revenue, 2024-2030
5.2.3 By Application - Global Retinal Drugs and Biologics Revenue Market Share, 2018-2030
5.3 By Application - Global Retinal Drugs and Biologics Sales & Forecasts
5.3.1 By Application - Global Retinal Drugs and Biologics Sales, 2018-2023
5.3.2 By Application - Global Retinal Drugs and Biologics Sales, 2024-2030
5.3.3 By Application - Global Retinal Drugs and Biologics Sales Market Share, 2018-2030
5.4 By Application - Global Retinal Drugs and Biologics Price (Manufacturers Selling Prices), 2018-2030
6 Sights by Region
6.1 By Region - Global Retinal Drugs and Biologics Market Size, 2022 & 2030
6.2 By Region - Global Retinal Drugs and Biologics Revenue & Forecasts
6.2.1 By Region - Global Retinal Drugs and Biologics Revenue, 2018-2023
6.2.2 By Region - Global Retinal Drugs and Biologics Revenue, 2024-2030
6.2.3 By Region - Global Retinal Drugs and Biologics Revenue Market Share, 2018-2030
6.3 By Region - Global Retinal Drugs and Biologics Sales & Forecasts
6.3.1 By Region - Global Retinal Drugs and Biologics Sales, 2018-2023
6.3.2 By Region - Global Retinal Drugs and Biologics Sales, 2024-2030
6.3.3 By Region - Global Retinal Drugs and Biologics Sales Market Share, 2018-2030
6.4 North America
6.4.1 By Country - North America Retinal Drugs and Biologics Revenue, 2018-2030
6.4.2 By Country - North America Retinal Drugs and Biologics Sales, 2018-2030
6.4.3 US Retinal Drugs and Biologics Market Size, 2018-2030
6.4.4 Canada Retinal Drugs and Biologics Market Size, 2018-2030
6.4.5 Mexico Retinal Drugs and Biologics Market Size, 2018-2030
6.5 Europe
6.5.1 By Country - Europe Retinal Drugs and Biologics Revenue, 2018-2030
6.5.2 By Country - Europe Retinal Drugs and Biologics Sales, 2018-2030
6.5.3 Germany Retinal Drugs and Biologics Market Size, 2018-2030
6.5.4 France Retinal Drugs and Biologics Market Size, 2018-2030
6.5.5 U.K. Retinal Drugs and Biologics Market Size, 2018-2030
6.5.6 Italy Retinal Drugs and Biologics Market Size, 2018-2030
6.5.7 Russia Retinal Drugs and Biologics Market Size, 2018-2030
6.5.8 Nordic Countries Retinal Drugs and Biologics Market Size, 2018-2030
6.5.9 Benelux Retinal Drugs and Biologics Market Size, 2018-2030
6.6 Asia
6.6.1 By Region - Asia Retinal Drugs and Biologics Revenue, 2018-2030
6.6.2 By Region - Asia Retinal Drugs and Biologics Sales, 2018-2030
6.6.3 China Retinal Drugs and Biologics Market Size, 2018-2030
6.6.4 Japan Retinal Drugs and Biologics Market Size, 2018-2030
6.6.5 South Korea Retinal Drugs and Biologics Market Size, 2018-2030
6.6.6 Southeast Asia Retinal Drugs and Biologics Market Size, 2018-2030
6.6.7 India Retinal Drugs and Biologics Market Size, 2018-2030
6.7 South America
6.7.1 By Country - South America Retinal Drugs and Biologics Revenue, 2018-2030
6.7.2 By Country - South America Retinal Drugs and Biologics Sales, 2018-2030
6.7.3 Brazil Retinal Drugs and Biologics Market Size, 2018-2030
6.7.4 Argentina Retinal Drugs and Biologics Market Size, 2018-2030
6.8 Middle East & Africa
6.8.1 By Country - Middle East & Africa Retinal Drugs and Biologics Revenue, 2018-2030
6.8.2 By Country - Middle East & Africa Retinal Drugs and Biologics Sales, 2018-2030
6.8.3 Turkey Retinal Drugs and Biologics Market Size, 2018-2030
6.8.4 Israel Retinal Drugs and Biologics Market Size, 2018-2030
6.8.5 Saudi Arabia Retinal Drugs and Biologics Market Size, 2018-2030
6.8.6 UAE Retinal Drugs and Biologics Market Size, 2018-2030
7 Manufacturers & Brands Profiles
7.1 ALLERGAN
7.1.1 ALLERGAN Company Summary
7.1.2 ALLERGAN Business Overview
7.1.3 ALLERGAN Retinal Drugs and Biologics Major Product Offerings
7.1.4 ALLERGAN Retinal Drugs and Biologics Sales and Revenue in Global (2018-2023)
7.1.5 ALLERGAN Key News & Latest Developments
7.2 AbbVie
7.2.1 AbbVie Company Summary
7.2.2 AbbVie Business Overview
7.2.3 AbbVie Retinal Drugs and Biologics Major Product Offerings
7.2.4 AbbVie Retinal Drugs and Biologics Sales and Revenue in Global (2018-2023)
7.2.5 AbbVie Key News & Latest Developments
7.3 Alimera Sciences
7.3.1 Alimera Sciences Company Summary
7.3.2 Alimera Sciences Business Overview
7.3.3 Alimera Sciences Retinal Drugs and Biologics Major Product Offerings
7.3.4 Alimera Sciences Retinal Drugs and Biologics Sales and Revenue in Global (2018-2023)
7.3.5 Alimera Sciences Key News & Latest Developments
7.4 Janssen Biotech
7.4.1 Janssen Biotech Company Summary
7.4.2 Janssen Biotech Business Overview
7.4.3 Janssen Biotech Retinal Drugs and Biologics Major Product Offerings
7.4.4 Janssen Biotech Retinal Drugs and Biologics Sales and Revenue in Global (2018-2023)
7.4.5 Janssen Biotech Key News & Latest Developments
7.5 Swedish Orphan Biovitrum
7.5.1 Swedish Orphan Biovitrum Company Summary
7.5.2 Swedish Orphan Biovitrum Business Overview
7.5.3 Swedish Orphan Biovitrum Retinal Drugs and Biologics Major Product Offerings
7.5.4 Swedish Orphan Biovitrum Retinal Drugs and Biologics Sales and Revenue in Global (2018-2023)
7.5.5 Swedish Orphan Biovitrum Key News & Latest Developments
7.6 Roche
7.6.1 Roche Company Summary
7.6.2 Roche Business Overview
7.6.3 Roche Retinal Drugs and Biologics Major Product Offerings
7.6.4 Roche Retinal Drugs and Biologics Sales and Revenue in Global (2018-2023)
7.6.5 Roche Key News & Latest Developments
7.7 Bristol-Myers Squibb
7.7.1 Bristol-Myers Squibb Company Summary
7.7.2 Bristol-Myers Squibb Business Overview
7.7.3 Bristol-Myers Squibb Retinal Drugs and Biologics Major Product Offerings
7.7.4 Bristol-Myers Squibb Retinal Drugs and Biologics Sales and Revenue in Global (2018-2023)
7.7.5 Bristol-Myers Squibb Key News & Latest Developments
7.8 Genzyme
7.8.1 Genzyme Company Summary
7.8.2 Genzyme Business Overview
7.8.3 Genzyme Retinal Drugs and Biologics Major Product Offerings
7.8.4 Genzyme Retinal Drugs and Biologics Sales and Revenue in Global (2018-2023)
7.8.5 Genzyme Key News & Latest Developments
7.9 Genentech
7.9.1 Genentech Company Summary
7.9.2 Genentech Business Overview
7.9.3 Genentech Retinal Drugs and Biologics Major Product Offerings
7.9.4 Genentech Retinal Drugs and Biologics Sales and Revenue in Global (2018-2023)
7.9.5 Genentech Key News & Latest Developments
7.10 OCULAR THERAPEUTIX
7.10.1 OCULAR THERAPEUTIX Company Summary
7.10.2 OCULAR THERAPEUTIX Business Overview
7.10.3 OCULAR THERAPEUTIX Retinal Drugs and Biologics Major Product Offerings
7.10.4 OCULAR THERAPEUTIX Retinal Drugs and Biologics Sales and Revenue in Global (2018-2023)
7.10.5 OCULAR THERAPEUTIX Key News & Latest Developments
7.11 Bausch & Lomb
7.11.1 Bausch & Lomb Company Summary
7.11.2 Bausch & Lomb Retinal Drugs and Biologics Business Overview
7.11.3 Bausch & Lomb Retinal Drugs and Biologics Major Product Offerings
7.11.4 Bausch & Lomb Retinal Drugs and Biologics Sales and Revenue in Global (2018-2023)
7.11.5 Bausch & Lomb Key News & Latest Developments
7.12 UCBCares
7.12.1 UCBCares Company Summary
7.12.2 UCBCares Retinal Drugs and Biologics Business Overview
7.12.3 UCBCares Retinal Drugs and Biologics Major Product Offerings
7.12.4 UCBCares Retinal Drugs and Biologics Sales and Revenue in Global (2018-2023)
7.12.5 UCBCares Key News & Latest Developments
8 Global Retinal Drugs and Biologics Production Capacity, Analysis
8.1 Global Retinal Drugs and Biologics Production Capacity, 2018-2030
8.2 Retinal Drugs and Biologics Production Capacity of Key Manufacturers in Global Market
8.3 Global Retinal Drugs and Biologics Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Retinal Drugs and Biologics Supply Chain Analysis
10.1 Retinal Drugs and Biologics Industry Value Chain
10.2 Retinal Drugs and Biologics Upstream Market
10.3 Retinal Drugs and Biologics Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Retinal Drugs and Biologics Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Key Players of Retinal Drugs and Biologics in Global Market
Table 2. Top Retinal Drugs and Biologics Players in Global Market, Ranking by Revenue (2022)
Table 3. Global Retinal Drugs and Biologics Revenue by Companies, (US$, Mn), 2018-2023
Table 4. Global Retinal Drugs and Biologics Revenue Share by Companies, 2018-2023
Table 5. Global Retinal Drugs and Biologics Sales by Companies, (K MT), 2018-2023
Table 6. Global Retinal Drugs and Biologics Sales Share by Companies, 2018-2023
Table 7. Key Manufacturers Retinal Drugs and Biologics Price (2018-2023) & (USD/MT)
Table 8. Global Manufacturers Retinal Drugs and Biologics Product Type
Table 9. List of Global Tier 1 Retinal Drugs and Biologics Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Retinal Drugs and Biologics Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type ? Global Retinal Drugs and Biologics Revenue, (US$, Mn), 2022 & 2030
Table 12. By Type - Global Retinal Drugs and Biologics Revenue (US$, Mn), 2018-2023
Table 13. By Type - Global Retinal Drugs and Biologics Revenue (US$, Mn), 2024-2030
Table 14. By Type - Global Retinal Drugs and Biologics Sales (K MT), 2018-2023
Table 15. By Type - Global Retinal Drugs and Biologics Sales (K MT), 2024-2030
Table 16. By Application ? Global Retinal Drugs and Biologics Revenue, (US$, Mn), 2022 & 2030
Table 17. By Application - Global Retinal Drugs and Biologics Revenue (US$, Mn), 2018-2023
Table 18. By Application - Global Retinal Drugs and Biologics Revenue (US$, Mn), 2024-2030
Table 19. By Application - Global Retinal Drugs and Biologics Sales (K MT), 2018-2023
Table 20. By Application - Global Retinal Drugs and Biologics Sales (K MT), 2024-2030
Table 21. By Region ? Global Retinal Drugs and Biologics Revenue, (US$, Mn), 2022 VS 2030
Table 22. By Region - Global Retinal Drugs and Biologics Revenue (US$, Mn), 2018-2023
Table 23. By Region - Global Retinal Drugs and Biologics Revenue (US$, Mn), 2024-2030
Table 24. By Region - Global Retinal Drugs and Biologics Sales (K MT), 2018-2023
Table 25. By Region - Global Retinal Drugs and Biologics Sales (K MT), 2024-2030
Table 26. By Country - North America Retinal Drugs and Biologics Revenue, (US$, Mn), 2018-2023
Table 27. By Country - North America Retinal Drugs and Biologics Revenue, (US$, Mn), 2024-2030
Table 28. By Country - North America Retinal Drugs and Biologics Sales, (K MT), 2018-2023
Table 29. By Country - North America Retinal Drugs and Biologics Sales, (K MT), 2024-2030
Table 30. By Country - Europe Retinal Drugs and Biologics Revenue, (US$, Mn), 2018-2023
Table 31. By Country - Europe Retinal Drugs and Biologics Revenue, (US$, Mn), 2024-2030
Table 32. By Country - Europe Retinal Drugs and Biologics Sales, (K MT), 2018-2023
Table 33. By Country - Europe Retinal Drugs and Biologics Sales, (K MT), 2024-2030
Table 34. By Region - Asia Retinal Drugs and Biologics Revenue, (US$, Mn), 2018-2023
Table 35. By Region - Asia Retinal Drugs and Biologics Revenue, (US$, Mn), 2024-2030
Table 36. By Region - Asia Retinal Drugs and Biologics Sales, (K MT), 2018-2023
Table 37. By Region - Asia Retinal Drugs and Biologics Sales, (K MT), 2024-2030
Table 38. By Country - South America Retinal Drugs and Biologics Revenue, (US$, Mn), 2018-2023
Table 39. By Country - South America Retinal Drugs and Biologics Revenue, (US$, Mn), 2024-2030
Table 40. By Country - South America Retinal Drugs and Biologics Sales, (K MT), 2018-2023
Table 41. By Country - South America Retinal Drugs and Biologics Sales, (K MT), 2024-2030
Table 42. By Country - Middle East & Africa Retinal Drugs and Biologics Revenue, (US$, Mn), 2018-2023
Table 43. By Country - Middle East & Africa Retinal Drugs and Biologics Revenue, (US$, Mn), 2024-2030
Table 44. By Country - Middle East & Africa Retinal Drugs and Biologics Sales, (K MT), 2018-2023
Table 45. By Country - Middle East & Africa Retinal Drugs and Biologics Sales, (K MT), 2024-2030
Table 46. ALLERGAN Company Summary
Table 47. ALLERGAN Retinal Drugs and Biologics Product Offerings
Table 48. ALLERGAN Retinal Drugs and Biologics Sales (K MT), Revenue (US$, Mn) and Average Price (USD/MT) (2018-2023)
Table 49. ALLERGAN Key News & Latest Developments
Table 50. AbbVie Company Summary
Table 51. AbbVie Retinal Drugs and Biologics Product Offerings
Table 52. AbbVie Retinal Drugs and Biologics Sales (K MT), Revenue (US$, Mn) and Average Price (USD/MT) (2018-2023)
Table 53. AbbVie Key News & Latest Developments
Table 54. Alimera Sciences Company Summary
Table 55. Alimera Sciences Retinal Drugs and Biologics Product Offerings
Table 56. Alimera Sciences Retinal Drugs and Biologics Sales (K MT), Revenue (US$, Mn) and Average Price (USD/MT) (2018-2023)
Table 57. Alimera Sciences Key News & Latest Developments
Table 58. Janssen Biotech Company Summary
Table 59. Janssen Biotech Retinal Drugs and Biologics Product Offerings
Table 60. Janssen Biotech Retinal Drugs and Biologics Sales (K MT), Revenue (US$, Mn) and Average Price (USD/MT) (2018-2023)
Table 61. Janssen Biotech Key News & Latest Developments
Table 62. Swedish Orphan Biovitrum Company Summary
Table 63. Swedish Orphan Biovitrum Retinal Drugs and Biologics Product Offerings
Table 64. Swedish Orphan Biovitrum Retinal Drugs and Biologics Sales (K MT), Revenue (US$, Mn) and Average Price (USD/MT) (2018-2023)
Table 65. Swedish Orphan Biovitrum Key News & Latest Developments
Table 66. Roche Company Summary
Table 67. Roche Retinal Drugs and Biologics Product Offerings
Table 68. Roche Retinal Drugs and Biologics Sales (K MT), Revenue (US$, Mn) and Average Price (USD/MT) (2018-2023)
Table 69. Roche Key News & Latest Developments
Table 70. Bristol-Myers Squibb Company Summary
Table 71. Bristol-Myers Squibb Retinal Drugs and Biologics Product Offerings
Table 72. Bristol-Myers Squibb Retinal Drugs and Biologics Sales (K MT), Revenue (US$, Mn) and Average Price (USD/MT) (2018-2023)
Table 73. Bristol-Myers Squibb Key News & Latest Developments
Table 74. Genzyme Company Summary
Table 75. Genzyme Retinal Drugs and Biologics Product Offerings
Table 76. Genzyme Retinal Drugs and Biologics Sales (K MT), Revenue (US$, Mn) and Average Price (USD/MT) (2018-2023)
Table 77. Genzyme Key News & Latest Developments
Table 78. Genentech Company Summary
Table 79. Genentech Retinal Drugs and Biologics Product Offerings
Table 80. Genentech Retinal Drugs and Biologics Sales (K MT), Revenue (US$, Mn) and Average Price (USD/MT) (2018-2023)
Table 81. Genentech Key News & Latest Developments
Table 82. OCULAR THERAPEUTIX Company Summary
Table 83. OCULAR THERAPEUTIX Retinal Drugs and Biologics Product Offerings
Table 84. OCULAR THERAPEUTIX Retinal Drugs and Biologics Sales (K MT), Revenue (US$, Mn) and Average Price (USD/MT) (2018-2023)
Table 85. OCULAR THERAPEUTIX Key News & Latest Developments
Table 86. Bausch & Lomb Company Summary
Table 87. Bausch & Lomb Retinal Drugs and Biologics Product Offerings
Table 88. Bausch & Lomb Retinal Drugs and Biologics Sales (K MT), Revenue (US$, Mn) and Average Price (USD/MT) (2018-2023)
Table 89. Bausch & Lomb Key News & Latest Developments
Table 90. UCBCares Company Summary
Table 91. UCBCares Retinal Drugs and Biologics Product Offerings
Table 92. UCBCares Retinal Drugs and Biologics Sales (K MT), Revenue (US$, Mn) and Average Price (USD/MT) (2018-2023)
Table 93. UCBCares Key News & Latest Developments
Table 94. Retinal Drugs and Biologics Production Capacity (K MT) of Key Manufacturers in Global Market, 2021-2023 (K MT)
Table 95. Global Retinal Drugs and Biologics Capacity Market Share of Key Manufacturers, 2021-2023
Table 96. Global Retinal Drugs and Biologics Production by Region, 2018-2023 (K MT)
Table 97. Global Retinal Drugs and Biologics Production by Region, 2024-2030 (K MT)
Table 98. Retinal Drugs and Biologics Market Opportunities & Trends in Global Market
Table 99. Retinal Drugs and Biologics Market Drivers in Global Market
Table 100. Retinal Drugs and Biologics Market Restraints in Global Market
Table 101. Retinal Drugs and Biologics Raw Materials
Table 102. Retinal Drugs and Biologics Raw Materials Suppliers in Global Market
Table 103. Typical Retinal Drugs and Biologics Downstream
Table 104. Retinal Drugs and Biologics Downstream Clients in Global Market
Table 105. Retinal Drugs and Biologics Distributors and Sales Agents in Global Market
List of Figures
Figure 1. Retinal Drugs and Biologics Segment by Type in 2022
Figure 2. Retinal Drugs and Biologics Segment by Application in 2022
Figure 3. Global Retinal Drugs and Biologics Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Retinal Drugs and Biologics Market Size: 2022 VS 2030 (US$, Mn)
Figure 6. Global Retinal Drugs and Biologics Revenue, 2018-2030 (US$, Mn)
Figure 7. Retinal Drugs and Biologics Sales in Global Market: 2018-2030 (K MT)
Figure 8. The Top 3 and 5 Players Market Share by Retinal Drugs and Biologics Revenue in 2022
Figure 9. By Type - Global Retinal Drugs and Biologics Revenue, (US$, Mn), 2022 & 2030
Figure 10. By Type - Global Retinal Drugs and Biologics Revenue Market Share, 2018-2030
Figure 11. By Type - Global Retinal Drugs and Biologics Sales Market Share, 2018-2030
Figure 12. By Type - Global Retinal Drugs and Biologics Price (USD/MT), 2018-2030
Figure 13. By Application - Global Retinal Drugs and Biologics Revenue, (US$, Mn), 2022 & 2030
Figure 14. By Application - Global Retinal Drugs and Biologics Revenue Market Share, 2018-2030
Figure 15. By Application - Global Retinal Drugs and Biologics Sales Market Share, 2018-2030
Figure 16. By Application - Global Retinal Drugs and Biologics Price (USD/MT), 2018-2030
Figure 17. By Region - Global Retinal Drugs and Biologics Revenue, (US$, Mn), 2022 & 2030
Figure 18. By Region - Global Retinal Drugs and Biologics Revenue Market Share, 2018 VS 2022 VS 2030
Figure 19. By Region - Global Retinal Drugs and Biologics Revenue Market Share, 2018-2030
Figure 20. By Region - Global Retinal Drugs and Biologics Sales Market Share, 2018-2030
Figure 21. By Country - North America Retinal Drugs and Biologics Revenue Market Share, 2018-2030
Figure 22. By Country - North America Retinal Drugs and Biologics Sales Market Share, 2018-2030
Figure 23. US Retinal Drugs and Biologics Revenue, (US$, Mn), 2018-2030
Figure 24. Canada Retinal Drugs and Biologics Revenue, (US$, Mn), 2018-2030
Figure 25. Mexico Retinal Drugs and Biologics Revenue, (US$, Mn), 2018-2030
Figure 26. By Country - Europe Retinal Drugs and Biologics Revenue Market Share, 2018-2030
Figure 27. By Country - Europe Retinal Drugs and Biologics Sales Market Share, 2018-2030
Figure 28. Germany Retinal Drugs and Biologics Revenue, (US$, Mn), 2018-2030
Figure 29. France Retinal Drugs and Biologics Revenue, (US$, Mn), 2018-2030
Figure 30. U.K. Retinal Drugs and Biologics Revenue, (US$, Mn), 2018-2030
Figure 31. Italy Retinal Drugs and Biologics Revenue, (US$, Mn), 2018-2030
Figure 32. Russia Retinal Drugs and Biologics Revenue, (US$, Mn), 2018-2030
Figure 33. Nordic Countries Retinal Drugs and Biologics Revenue, (US$, Mn), 2018-2030
Figure 34. Benelux Retinal Drugs and Biologics Revenue, (US$, Mn), 2018-2030
Figure 35. By Region - Asia Retinal Drugs and Biologics Revenue Market Share, 2018-2030
Figure 36. By Region - Asia Retinal Drugs and Biologics Sales Market Share, 2018-2030
Figure 37. China Retinal Drugs and Biologics Revenue, (US$, Mn), 2018-2030
Figure 38. Japan Retinal Drugs and Biologics Revenue, (US$, Mn), 2018-2030
Figure 39. South Korea Retinal Drugs and Biologics Revenue, (US$, Mn), 2018-2030
Figure 40. Southeast Asia Retinal Drugs and Biologics Revenue, (US$, Mn), 2018-2030
Figure 41. India Retinal Drugs and Biologics Revenue, (US$, Mn), 2018-2030
Figure 42. By Country - South America Retinal Drugs and Biologics Revenue Market Share, 2018-2030
Figure 43. By Country - South America Retinal Drugs and Biologics Sales Market Share, 2018-2030
Figure 44. Brazil Retinal Drugs and Biologics Revenue, (US$, Mn), 2018-2030
Figure 45. Argentina Retinal Drugs and Biologics Revenue, (US$, Mn), 2018-2030
Figure 46. By Country - Middle East & Africa Retinal Drugs and Biologics Revenue Market Share, 2018-2030
Figure 47. By Country - Middle East & Africa Retinal Drugs and Biologics Sales Market Share, 2018-2030
Figure 48. Turkey Retinal Drugs and Biologics Revenue, (US$, Mn), 2018-2030
Figure 49. Israel Retinal Drugs and Biologics Revenue, (US$, Mn), 2018-2030
Figure 50. Saudi Arabia Retinal Drugs and Biologics Revenue, (US$, Mn), 2018-2030
Figure 51. UAE Retinal Drugs and Biologics Revenue, (US$, Mn), 2018-2030
Figure 52. Global Retinal Drugs and Biologics Production Capacity (K MT), 2018-2030
Figure 53. The Percentage of Production Retinal Drugs and Biologics by Region, 2022 VS 2030
Figure 54. Retinal Drugs and Biologics Industry Value Chain
Figure 55. Marketing Channels
